Christopher Smith

Christopher Smith

Adelaide Medical School

Faculty of Health and Medical Sciences

Working in the fields of Intensive Care and Pre-Hospital and Retrieval medicine in Adelaide, with a practice spanning general and cardiothoracic ICU and pre-hospital and retrieval medicine, Dr Smith's work sits at the intersection of bedside care, clinical governance, and medical education to improve quality of care provided to South Australians. Clinical and academic interests include critical care diagnostics (respiratory infection), cardiothoracic intensive care and ECMO, airway management and peri-procedural safety, clinical governance, mortality review, and quality improvement, in addition to medical education and curriculum design within postgraduate medical education.

  • Smith CD, De Luca A, Hibbert P, Sundararajan K. Reducing postoperative blood product usage and costs in cardiothoracic surgery: implementation of a multispecialty perioperative care model incorporating a haemostasis checklist. BMJ Open Quality 2025;14:e002911.
  • Smith CD, Patel M. “Ticked off”? Can a new outcomes-based postgraduate curriculum using programmatic assessment reduce assessment burden in Intensive Care Medicine? Journal of Intensive Care Medicine 2022. doi:10.1177/17511437211061642.
  • Smith CD, Robert S. ‘Designer drugs’: update on the management of novel psychoactive substance misuse in the acute care setting. Clinical Medicine 2014;14(4):409–415. doi:10.7861/clinmedicine.14-4-409.
  • Pywell S, Smith CD, Reynolds P. Controversy and consent: achieving patient autonomy in thrombolysis for acute submassive pulmonary embolism. BMJ Case Reports 2015. doi:10.1136/bcr-2015-209390.
  • Smith CD, Robert S. Designer Drugs—New Challenges: update on management of novel psychoactive substance toxicity in critical care. Intensive Care Medicine 2013 (Suppl. 1):S82–S83. doi:10.1007/s00134-013-3451-5.
  • Smith CD, Williams M, Shaikh M. Novel psychoactive substances: a novel clinical challenge. BMJ Case Reports 2013. doi:10.1136/bcr-2013-200663.
  • Smith CD (summary author). ARiE trial—rifaximin for encephalopathy. The Bottom Line.

  • Journals
    Year Citation
    2025 Smith, C. D., De Luca, A., Hibbert, P., & Sundararajan, K. (2025). Reducing postoperative blood product usage and costs in cardiothoracic surgery: the implementation of a multispecialty perioperative care model incorporating a haemostasis checklist. BMJ Open Quality, 14(1), 7 pages.
    DOI
    2025 Harris, T., Bhanderi, N., Harris, D., Smith, C., Breslin, R., Moran, J., . . . Barnard, E. (2025). Air Transport Medicine: From the Field. Air Medical Journal, 1-3.
    DOI
    2023 Smith, C., & Patel, M. (2023). ‘Ticked off’? Can a new outcomes-based postgraduate curriculum utilising programmatic assessment reduce assessment burden in Intensive Care Medicine?. Journal of the Intensive Care Society, 24(2), 170-177.
    DOI
    2014 Smith, C. D., & Robert, S. (2014). ‘Designer drugs’: update on the management of novel psychoactive substance misuse in the acute care setting. Clinical Medicine, 14(4), 409-415.
    DOI
    - Pywell, S. R., Smith, C. D., & Reynolds, P. (2015). Controversy and consent: achieving patient autonomy in thrombolysis for acute submassive pulmonary embolism. BMJ Case Reports, 2015, bcr2015209390.
    DOI
    - Smith, C. D., Williams, M., & Shaikh, M. (2013). Novel psychoactive substances: a novel clinical challenge. BMJ Case Reports, 2013, bcr2013200663.
    DOI
Connect With Me